Profile
The Bristol Myers Squibb and Pfizer alliance is a worldwide collaboration bringing together two leading
companies focused on cardiovascular disease with a shared vision to reduce NVAF-related stroke and
treat DVT/pulmonary embolism events.
Pfizer and Bristol-Myers Squibb are partners in a worldwide collaboration. This global alliance combines both Bristol-Myers Squibb's and Pfizer’s long-standing strengths in drug development and commercialization.